biotech
Bio-AnalystSupplement research
person

Niacin

Selected research topic

Blood pressure and vascular health

The comparison is unconfirmed, so the findings cannot establish this ingredient’s effect.

Some findings concern patients or people with a deficiency.

Publications for this topic
1
Human comparison publications
0
Publications needing review
0

Findings in the studies

  • BP

    Research with unclear study subject or type
    • A change was reported, but the comparison could not be confirmed.
      Patient group · Single ingredient
      Measurement and study conditions
      • Review
      • Review
      • Single ingredient
      • Patient group
      • Outcome role not specified
      • Study subject not identified
      • Timepoint: acute and chronic effects discussed
      • Study comparison: review-level synthesis; no pooled comparison
Representative outcome and study details

Studies with an unspecified organism reported a change with no confirmed comparison group in BP.

Single-ingredient studies · Includes patient groups · comparator not confirmed

1 publications linked to this result

  • Route, form, dose, or population details are incomplete, so the findings cannot be confirmed as directly comparable.
Data coverage and detailed study classifications

Paper counts are separated by research topic below. One paper may contribute to multiple findings.

Analysis status: Public-ready

Ingredient analysis date:

How the grade was determined: C

The 16.3 evidence score includes 0 independent human studies and 0 clinical studies in the representative benefit area. The C tier remains conservative because of limited repetition across independent human clinical studies, too few clinical findings with an explicit effect direction.

The grade is based mainly on the research area with the most evidence. It does not mean the same result was found in other areas.

Papers linked to this ingredient overall: 59

Papers linked to this topic 1 · distinct papers 1 · comparison findings need further review · papers needing additional review 0

A publication may appear in more than one count. These numbers should not be added. Ingredient-wide papers, topic-linked papers, and sources in outcome groups use different scopes. Adding source counts may count the same paper more than once.

  • BP: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0

What the research found

BP

A change was reported, but the comparison could not be confirmed.

Review · Single ingredient · Patient group

Analysis coverage and paper counts

1 paper · 1 measured outcome

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

How to read research findings

How should I read research findings?

Research guides

Side effects and combination findings

Findings from this ingredient alone are shown separately from those involving another supplement or medication.

No reviewed caution rules are available yet. Reported caution findings are shown below.

Findings to review with care

Side effects reported for the ingredient alone are separated from findings involving another supplement or medication.

Side effects reported with this ingredient alone

Symptoms or adverse events reported in studies without another active ingredient.

Cutaneous vasodilation (flushing)1 papers
Niacin causes cutaneous vasodilation (flushing) as a strong side effect when used to treat dyslipidemias.Human studies · Study type not identified

Cautions reported with another supplement or medication

These studies reported worsening outcomes, reduced absorption, or other cautions with combined use. They do not predict an individual's outcome.

스타틴Increased risk of all-cause mortality observed when niacin is combined with statins.